Missing/wrong data?
Log in to edit
Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.
scientific article
Author/s
author: Wojciech Jurczak, Alicja M Gruszka, Pier Luigi Zinzani, Monika Długosz-Danecka, Aleksander Skotnicki, Marta Szostek, Alicja Hubalewska-Dydejczyk, Tomasz Wróbel, Agnieszka Giza, Wanda Knopinska-Posluszny
Work details
Publication date
April 9, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.